Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Antifungal activity and good tolerability in phase I trial of L-743872

May 24, 1996

Abelcet approved for marketing in Portugal

May 24, 1996

Antifungal antibiotic YM-47522 isolated by Yamanouchi

May 24, 1996

L-749345 in clinical trials at Merck & Co.

May 24, 1996

AmBisome approved in India

May 17, 1996

HNK20 moves to phase III

May 17, 1996

CMV NeutraGAM development update

May 17, 1996

Interferon Sciences reacquires U.S. and Canadian marketing rights for interferon product

May 17, 1996

IDEC receives NIAID grant to develop MAbs for RSV

May 17, 1996

Nippon Shoji to collaborate on nisin development in Pacific rim countries

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...